Market Overview

ContraVir Says SEC Filing Made In Error, Stock Moves Down


ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV) said Friday that its recent registration withdrawal was filed in error.

The ContraVir Pharma "RW" filing was made Thursday. The SEC RW filing is made by companies requesting to formally withdraw a pending securities registration.

ContraVir shares were down 10.98% at $9 at the time of publication Friday. 

Related Links:

Why Low-Float, Thinly Traded ContraVir Pharma's Rally Is Continuing

Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates

Posted-In: Biotech News General


Related Articles (CTRV)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial

Huawei Delays Foldable Phone Launch

E3: Morgan Stanley's 6 Takeaways